ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

VSTM Verastem Inc

3,44
-0,20 (-5,49%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Verastem Inc VSTM NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,20 -5,49% 3,44 20:59:12
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
3,59 3,39 3,64 3,40 3,64
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/05/202408:00BWVerastem Oncology Announces the Initiation of a Rolling..
23/05/202418:01BWVerastem Oncology Announces Positive Initial Interim Safety..
09/05/202417:02BWVerastem Oncology Reports First Quarter 2024 Financial..
07/05/202408:30BWVerastem Oncology to Present at the RBC Capital Markets..
18/04/202417:05BWVerastem Oncology Announces Appointment of John Hayslip,..
04/04/202408:30BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
18/03/202408:00BWGlobal Patient Survey Results Reveal Significant Negative..
14/03/202417:05BWVerastem Oncology Reports Fourth Quarter and Full Year 2023..
11/03/202408:30BWVerastem Oncology Announces Multiple Oral Presentations at..
05/03/202419:27BWVerastem Oncology Receives Orphan Drug Designation from FDA..
05/03/202418:30BWVerastem Oncology Announces Preclinical Presentations for..
29/01/202409:00BWVerastem Oncology Outlines Key 2024 Strategic Priorities and..
18/01/202418:00BWVerastem Oncology Granted Fast Track Designation for..
11/01/202409:00BWVerastem Oncology to Participate in the B. Riley Securities..
05/01/202409:00BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
18/12/202309:00BWVerastem Oncology Selects Oral KRAS G12D Inhibitor..
13/12/202309:00BWVerastem Oncology Announces Initiation of a Confirmatory..
13/11/202309:00BWNew Healthcare Professional Component of Let’s Talk About..
08/11/202318:12BWVerastem Oncology Reports Third Quarter 2023 Financial..
07/11/202309:00BWFirst-Of-Its-Kind, Multi-National Patient Impact Survey..
06/11/202309:00BWVerastem Oncology Announces Efficacy and Safety Data of..
26/10/202317:05BWVerastem Oncology Strengthens Executive Leadership Team with..
18/10/202317:50BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
14/10/202313:30BWVerastem Oncology Announces Initial Results of RAMP 203..
06/10/202308:00BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
28/09/202315:15BWVerastem Presents Avutometinib and Defactinib Combination..
05/09/202308:00BWVerastem Oncology to Participate in Upcoming Investor..
28/08/202308:00BWVerastem Oncology Enters Discovery and Development..
08/08/202317:05BWVerastem Oncology Reports Second Quarter 2023 Financial..
11/07/202308:00BWVerastem Oncology Announces Promotion of Dan Paterson to..
10/07/202317:05BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
05/07/202317:05BWVerastem Oncology Announces Design for Confirmatory Trial of..
16/06/202306:00BWVerastem Oncology Announces Pricing of $85.0 Million Public..
15/06/202317:00BWVerastem Oncology Announces Proposed Public Offering of..

Seu Histórico Recente

Delayed Upgrade Clock